Healthcare Reform in China.pptVIP

R E L A T E D R E P O R T S: Please refer to the back of this pack for a list of related titles R E L A T E D R E P O R T S: Please refer to the back of this pack for a list of related titles ! Author: Experience: Companies: Qualifications: Expertise: Companies profiled: Reference Code: Publication Date: Full report: Module: Regions/countries: R E L A T E D R E P O R T S: Please refer to the back of this pack for a list of related titles R E L A T E D R E P O R T S: Please refer to the back of this pack for a list of related titles ! Stakeholders covered: Reforms examined: Reference Code: Publication Date: Full report: Module: Regions/countries: Related Reports Healthcare Reform in China Assessment of changes to pricing, regulation, and infrastructure, and opportunities for stakeholders BI00050-012 October 2011 112 pages ,13 figures, 13 tables Strategy China National insurance reforms National reimbursement lists Drug price reforms Hospital drug distribution reforms Clinic and hospital investments Health IT reforms Pharmaceutical companies CROs Private health insurers Hospitals Healthcare IT providers China’s pharma market to reach $100bn by 2016 China’s pharmaceutical market will grow at a CAGR of 17% to exceed $100bn in 2016, becoming the third largest market globally Population is forecast to increase by 85m people between 2010 and 2020. 85% of this will be accounted for by an increase in over 60s. China’s ageing population will prompt growth in markets for cardiovascular diseases, dementia, and other age-linked conditions. Ch. 1 China’s Changing Population Sec: Introduction ; Change in therapeutic focus Source: International Diabetes Federation; Yang et al, 2010 China’s middle class to increase by 80% from 2010 to 2015 China’s population is becoming increasingly urbanized creating opportunities for multinational firms in areas such as clinical trials By 2016, China will have more urban than rural citizens 2nd and 3rd tier citi